ALFREDO
RODRIGUEZ-ANTIGUEDAD ZARRANZ
PROFESORADO ASOCIADO
![Foto de ALFREDO](/img/nophoto.png)
![Foto de Pharmacoeconomics and Outcomes Research Iberia](/img/noimage_org.png)
Pharmacoeconomics and Outcomes Research Iberia
Pozuelo de Alarcón, EspañaPublikationen in Zusammenarbeit mit Forschern von Pharmacoeconomics and Outcomes Research Iberia (1)
2023
-
Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain
PharmacoEconomics - Open, Vol. 7, Núm. 3, pp. 431-441